Adult Onset Still's Disease
Also known as: Adult's Still Disease / Adult-Onset Still´s Disease / Adult-Onset Still Disease / Adult Onset Still Disease / Adult-Onset Still's Disease / Still's disease adult onset / Still's Disease, Adult-Onset / Still Disease, Adult-Onset / AOSD / Adult onset Still's disease (disorder) / Juvenile rheumatoid arthritis with systemic onset / Still's disease / Systemic onset juvenile chronic arthritis (disorder) / Juvenile-Onset Still Disease
Drug | Drug Name | Drug Description |
---|---|---|
DB06168 | Canakinumab | An interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA). |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06168 | Canakinumab | Interleukin-1 beta | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00026 | Anakinra | 2 | Completed | 1 |
DB00993 | Azathioprine | 2 | Completed | 1 |
DB06168 | Canakinumab | 2 | Terminated | 1 |
DB14724 | Emapalumab | 2 | Completed | 1 |
DB01097 | Leflunomide | 2 | Completed | 1 |
DB00563 | Methotrexate | 2 | Completed | 1 |
DB06372 | Rilonacept | 2 | Completed | 1 |
DB14858 | Tadekinig alfa | 2 | Completed | 1 |
DB06273 | Tocilizumab | 2 | Unknown Status | 1 |
DB00026 | Anakinra | 3 | Recruiting | 1 |
DB00026 | Anakinra | 3 | Terminated | 1 |
DB06168 | Canakinumab | 3 | Active Not Recruiting | 1 |
DB16396 | Goflikicept | 3 | Withdrawn | 1 |